Close

Full FDA Approval of Keryx's (KERX) Zerenex Expected - Roth Capital

September 2, 2014 9:00 AM EDT Send to a Friend
Roth Capital affirms Keryx Biopharma (Nasdaq; KERX) at Buy into the September 7th PDUFA date for Zerenex.Analyst Joseph Pantginis sees ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login